VIVES Funds

VIVES is a seed capital fund initiated by UCLouvain which invests in companies developing disruptive innovations with a positive societal impact.

Yannick Vancoppenolle

Partner

5 past transactions

BiocSol

Seed Round in 2024
BiocSol focus on sustainable microbial-based crop protection.

ATB Therapeutics

Series A in 2024
ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.

Generare

Seed Round in 2024
Generare is a biotechnology company specializing in the discovery of novel drug leads derived from soil bacteria. It has created a comprehensive map of the biosynthetic landscape, utilizing experimental data to predict and access valuable new molecules with novel modes of action, thereby aiding pharmaceutical companies and research institutions in drug development.

Brightflow

Series A in 2024
Brightflow operates as a medical device startup.

VOCSense

Seed Round in 2021
VOCSense is a technology company focused on sensing solutions for environmental monitoring. Originating as a spin-off, it is developing EnviCam, an environmental camera that makes visible the chemical and biochemical molecules surrounding us, and has created CMOSEnvi, a manufacturing process compatible with standard CMOS chips. The company manufactures microelectronic gas sensors and integrates nanotech-based sensing materials to convert raw electrical signals into accurate concentration data using proprietary AI algorithms. Its sensors and analytics serve agriculture, food, chemical, wastewater, and pharmaceutical industries, and support monitoring and control of industrial emissions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.